InflaRx (IFRX) Value Adjusted for Debt and Cash
The prospects for InflaRx N.V. (IFRX) rely on the efficacy of C5a protein blocking during acute inflammation and the approval of therapy by insurers. This chart of Separate Enterprise Value price action currently reflects a level of 51.82. Experienced top managers are developing unique antibodies to combat systemic pathologies, while the company strictly adheres to regulations regarding the disposal of laboratory waste and office paper.
InflaRx (IFRX) - metric breakdowns and financial figures
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Comprehensive company analysis:InflaRx N.V. (IFRX)
The scaling of Gohibic sales and the success of C5a inhibitor clinical trials drive the investment attractiveness of InflaRx N.V. (IFRX). The trend in enterprise value combines market capitalization with net debt, reflecting the actual cost of a full business buyout. This metric accounts for cash reserves, neutralizing the impact of borrowed capital on the valuation. Analysis of this chart allows for the identification of hidden debt risks. The final figure demonstrates the fair enterprise value for a strategic investor.
Competitor analysis for InflaRx N.V.
argenx N.V. - Full Business Value|Total Company Value BioNTech Group (BNTX)|Abivax Pharma (ABVX) - Value Adjusted for Debt and Cash|Real Price to Acquire Entire Company ADMA Biologics|PTGX (protagonist-inc.com) - Business Value|Total Company Value Immunovant IMVT|Full Business Value Kiniksa Pharmaceuticals, Ltd.|Grifols Group (GRFS) - Enterprise Value|Value Adjusted for Debt and Cash Adaptive Biotechnologies Inc. (ADPT)|Enterprise Value CLDX (Celldex Therapeutics)|auriniapharma.com - Enterprise Value|Total Company Value BioCryst Pharmaceuticals (BCRX)|VERA: Value Adjusted for Debt and Cash|DNTH (Dianthus Pharma) - Total Company Value|Pharvaris Pharma (PHVS) - Real Price to Acquire Entire Company|ABCL (AbCellera Biologics Inc) - Enterprise Value|Enterprise Value tourmalinebio.com (TRML)|Precigen (PGEN) - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash Pharming Group NV (PHAR)|Enterprise Value NKTR|Upstream Pharma - Company Buyout Price|ZBIO: Total Company Value|IMNM: Real Price to Acquire Entire Company|GOSS (Gossamer Bio) - Total Company Value|Real Price to Acquire Entire Company KalVista Pharma|SEPN (Septerna Corp) - Real Price to Acquire Entire Company|Enterprise Value PVLA|Total Company Value Savara Inc. SVRA|Business Value rigel.com (RIGL)|ANAB: Enterprise Value|Total Enterprise Value Astria Therapeutics Inc ATXS|Enterprise Value ENGN (enGene Bio)|RAPT: Company Buyout Price|Total Company Value aerovatetx.com|aclaristx.com (ACRS) - Business Value|Enterprise Value Kyverna Therapeutics, Inc. KYTX|Full Business Value TLSA|Total Company Value Cabaletta Bio, Inc (CABA)|Total Company Value Ventyx Biosciences, Inc (VTYX)|Enterprise Value THTX (Theratechnologies Inc.)|avalotx.com - Enterprise Value|Total Company Value Eledon Pharmaceuticals, Inc. (ELDN)|Agenus, Inc. (AGEN) - Value Adjusted for Debt and Cash|Real Price to Acquire Entire Company Climb Bio, Inc.|Business Value Zura Bio Ltd|ATYR - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash ADAG|Total Company Value ImageneBio Inc IMA|Business Value shattucklabs.com STTK|Real Price to Acquire Entire Company EQ|CNTB - Company Buyout Price|IMUX - Real Price to Acquire Entire Company|Atara Biotherapeutics (ATRA) - Total Company Value|X4 Pharmaceuticals, Inc. - Real Price to Acquire Entire Company|Adicet Bio, Inc. (ACET) - Company Buyout Price|CELU: Enterprise Value|Company Buyout Price INmune Bio Corporation|BRNS - Enterprise Value|Full Business Value KZR (kezarlifesciences.com)|Total Company Value SAB Biotherapeutics, Inc.|AKTX - Value Adjusted for Debt and Cash|Enlivex Therapeutics, Ltd. (ENLV) - Real Price to Acquire Entire Company|QTTB: Business Value|Total Company Value GeoVax Labs, Inc. (GOVX)|edesabiotech.com (EDSA) - Full Business Value|IBIO - Enterprise Value|Value Adjusted for Debt and Cash Carisma Tx|Enterprise Value XTLB|Enterprise Value BOLT (boltbio.com)|Total Company Value HCW Biologics|Aptevo Therapeutics, Inc. - Value Adjusted for Debt and Cash|AIM: Total Company Value|ADTX - Real Price to Acquire Entire Company|GRI: Enterprise Value|Enterprise Value XORTX Corp|HIND - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash revbiosciences.com|INDP (Indaptus Therapeutics, Inc.) - Enterprise Value|Company Buyout Price SCNI (Scinai Immunotherapeutics Ltd)|CalciMedica - Total Company Value|Affimed NV - Real Price to Acquire Entire Company|ALLK: Total Company Value|HOOKIPA Pharma Inc. (HOOK) - Real Price to Acquire Entire Company|IGMS: Real Price to Acquire Entire Company|ITOS (iTeos Therapeutics Inc) - Enterprise Value|Total Company Value Ocean Bio (OCEA)|Business Value TC BioPharm Ltd|Third Harmonic Bio - Enterprise Value